{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T13:22:55Z","timestamp":1783171375436,"version":"3.54.6"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["304105"],"award-info":[{"award-number":["304105"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.thromres.2026.109725","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T15:51:21Z","timestamp":1780069881000},"page":"109725","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Current practices in the use and monitoring of intravenous unfractionated heparin infusions \u2014 A cross-sectional UK survey"],"prefix":"10.1016","volume":"262","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4197-8294","authenticated-orcid":false,"given":"Jignesh P.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4378-8788","authenticated-orcid":false,"given":"Rosalind","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1668-8925","authenticated-orcid":false,"given":"Nathan","family":"Hutchinson-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4561-7173","authenticated-orcid":false,"given":"Joseph F.","family":"Standing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1700-3972","authenticated-orcid":false,"given":"Louise","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2892-1245","authenticated-orcid":false,"given":"Bryony Dean","family":"Franklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4315-3704","authenticated-orcid":false,"given":"Julia","family":"Czuprynska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2026.109725_bb0005","series-title":"World Health Organization Model List of Essential Medicines \u2013 22nd List","year":"2021"},{"key":"10.1016\/j.thromres.2026.109725_bb0010","series-title":"Medication Safety for High-Alert","author":"Institute for Safe Medication Practices","year":"2017"},{"key":"10.1016\/j.thromres.2026.109725_bb0015","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/bmjqs-2019-010206","article-title":"Economic analysis of the prevalence and clinical and economic burden of medication error in England","volume":"30","author":"Elliott","year":"2021","journal-title":"BMJ Qual. Saf."},{"key":"10.1016\/j.thromres.2026.109725_bb0020","series-title":"Medication Without Harm - Global Patient Safety Challenge on Medication Safety","year":"2017"},{"issue":"7","key":"10.1016\/j.thromres.2026.109725_bb0025","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1056\/NEJM197208172870703","article-title":"A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time","volume":"287","author":"Basu","year":"1972","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2026.109725_bb0030","series-title":"Bennett Institute for Applied Data Science","author":"OpenPrescribing.net","year":"2025"},{"issue":"4","key":"10.1016\/j.thromres.2026.109725_bb0035","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/bjh.19729","article-title":"Measurement of heparin, direct oral anti-coagulants and other non-coumarin anti-coagulants and their effects on haemostasis assays: A British Society for Haematology Guideline","volume":"205","author":"Baker","year":"2024","journal-title":"Br. J. Haematol."},{"issue":"11","key":"10.1016\/j.thromres.2026.109725_bb0040","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1111\/jth.13476","article-title":"A comparison of red blood cell transfusion utilization between anti-activated factor X and activated partial thromboplastin monitoring in patients receiving unfractionated heparin","volume":"14","author":"Belk","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2026.109725_bb0045","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1093\/ajhp\/zxz229","article-title":"Failure mode and effects analysis to reduce risk of heparin use","volume":"76","author":"Pino","year":"2019","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"5","key":"10.1016\/j.thromres.2026.109725_bb0050","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.jtha.2025.02.012","article-title":"Results of an international survey on the management of therapeutic intensity unfractionated heparin: communication from the SSCs of the ISTH","volume":"23","author":"Gouin-Thibault","year":"2025","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2026.109725_bb0055","article-title":"Understanding the causes of intravenous medication administration errors in hospitals: a qualitative critical incident study","volume":"5","author":"Keers","year":"2015","journal-title":"Br. Med. J. Open"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826001441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826001441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T13:11:05Z","timestamp":1783170665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384826001441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":11,"alternative-id":["S0049384826001441"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109725","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current practices in the use and monitoring of intravenous unfractionated heparin infusions \u2014 A cross-sectional UK survey","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109725","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109725"}}